Neoadjuvant immunotherapystereotactic body radiation therapySBRTcemiplimabBRANY IRBHCC
… ~55% disease-free survival (DFS) at 2 years with surveillance. Neoadjuvant immunotherapy induces tumor necrosis and may reduce the risk of local and dis…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,341–2,400 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Interferential therapy (IFT)1Intestinal transplant1Intestinal ultrasound1Intra-articular corticosteroid (IACS) injection1Intra-articular corticosteroid injections1Intracerebral dopamine cell transplants1Intralesional corticosteroid therapy1Intrapleural fibrinolytic treatment1Intrasaccular flow disruption1Intrathecal drug delivery1Intratympanic steroid therapy1Intravenous (IV) fluid therapy1Intravenous medicine administration1Intravenous potassium supplementation1Intravesical BCG instillations1Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy1Intravitreal therapies1Irreversible electroporation (IRE)1JAK inhibitors1Joint replacement1Jugular vein stenting1K-wire fixation1Ketamine-assisted psychotherapy1LAMS1LD-XRT1LDKTrelativeyearsgained1LDKTsurvival1LN induction treatment1LPA-targeted therapies1LRT1LTNIV1LV lead placement1LVAD implantation1LVR1Labor analgesia1Labour epidural analgesia1Laparoscopic surgery1Laparoscopy1Lateral femoral cutaneous nerve block1Left atrial ablation1Left ventricular assist devices1Level 1 disability management1Lipid Lowering TherapyPrescribed1Lipid-lowering therapies1Lokomat rehabilitation1Long term dopamine agonist therapy1Long-acting antiretroviral therapy1Long-acting injectable antiretroviral therapy1Low-dose ketamine infusion1Lumbar spine surgeries1Lymphatic Microsurgical Preventive Healing Approach1Lymphaticovenous anastomosis (LVA)1MATRix protocol1MB-TRAIL M28z CAR-T cell therapy1MBC regimen1MBE1MCMV peptide-epitope therapy1MDMA-assisted psychotherapy1MDT1MDT therapy programmes1
Articles mentioning treatments
7,227 articles · page 58 of 603Immunotherapycancers
…Background Immunotherapy has become an essential therapeutic strategy in the treatment o…
immunotherapyanti-PD-1 therapyWest China Hospital of Sichuan UniversityInstitutional Review BoardCRCAkkClinicalTrials.govMSS CRC
…s with higher Akk abundance showed better clinical responses to immunotherapy. The phase I trial (N=20) demonstrated favorable safety: 70% (1…
immunotherapyanti-PD-1 therapyWest China Hospital of Sichuan UniversityAkkInstitutional Review BoardCRCClinicalTrials.govMSS CRC
…s with higher Akk abundance showed better clinical responses to immunotherapy. The phase I trial (N = 22) demonstrated favorable safety: 86% …
anti-PD-1 therapynivolumabRP1Vusolimogene oderparepvecmelanoma
…0-mutant melanoma as first-line therapy or after progression on anti-PD-1 therapy. However, prior treatment with BRAF-directed therapy can dimini…
chemotherapyLung cancerbevacizumabPD-1 inhibitoradvanced driver gene-negative nsNSCLC
… gene-negative nsNSCLC patients, first-line PD-1 inhibitor plus chemotherapy demonstrated significantly improved PFS compared to bevacizumab…
chemotherapyimmuno-chemotherapyimmune checkpoint inhibitorsClinicalTrials.govZhongda Hospital Affiliated to Southeast UniversityBTCadvanced biliary tract cancer
… has been updated to immune checkpoint inhibitors combined with chemotherapy. However, immuno-chemotherapy for BTC still demonstrates signif…
T-FUSUniversity of Virginia[89Zr]-αCD47[89Zr]-aCD47breast cancersolid tumorsNIH DP5OD031846breast tumors[18F]-Fludeoxyglucose
… 2 and 5 post-treatment using a Philips EPIQ scanner. Following T-FUS, mice received intravenous (i.v.) injection of [18F]-Fludeoxygl…
surgerymelanomaBrown University HealthipilimumabnivolumabBrain metastasesadvanced melanomaLifespan- Rhode Island Hospital Institutional Review BoardICI
… ICI with surgery may improve survival in MBM patients. Upfront surgery was associated with longer progression-free survival but not ov…
immunotherapynon-small cell lung cancerpancreatic ductal adenocarcinoma
…, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168:707–723.Chowell D, Yoo S-K, Valero C, Pastore A…
chemotherapyimmunotherapyPancreatic ductal adenocarcinoma (PDAC)gemcitabine
… higher MPO activity in circulating neutrophils correlated with chemotherapy resistance.Conclusions Overall, our study demonstrates the crit…
chemotherapyFOLFIRINOXPancreatic cancerWest Virginia Universitygemcitabinegemcitabine-based
…ered in pancreatic disease, especially after treatments such as chemotherapy. The goal of this study is to characterize monocyte subsets in …